2021 American Transplant Congress

TOPIC: Clinical Science » Infectious Disease » All Infections (Excluding Kidney & Viral Hepatitis)

Randomized Phase 3 Open-label Study of Maribavir vs Investigator-assigned Therapy for Refractory/resistant Cytomegalovirus Infection in Transplant Recipients: Subgroup Analyses of Efficacy by Organ
R. K. Avery¹, E. A. Blumberg², D. Florescu³, N. Kamar⁴, D. Kumar⁵, J. Wu⁶, A. Sundberg⁶
Relationship Between Tacrolimus Blood Levels and Covid-19 Pandemic in Kidney Transplant Recipients
T. Inoue¹, K. Unagami,², A. Ishiwatari³, T. Kanzawa³, T. Shimizu³, K. Omoto³, M. Inui³, T. Suzuki¹, H. Ishida⁴, K. Tanabe³
Risk Factors and Outcomes of Neutropenia in Kidney Transplant Recipients
R. Avery¹, J. Motter¹, S. Sae-Tia², N. Lu¹, W. Cochran¹, A. Massie¹, D. Brennan¹, F. Akinwande¹, S. Shoham¹, E. Kraus¹, N. Alachkar¹, S. Alasfar¹, F. Naqvi¹, F. Al Ammary¹, K. Marr¹, S. Mehta Steinke¹, N. Desai¹, O. Ezennia¹, P. Plummer¹, C. Durand¹, W. Werbel¹, M. Y. Kim¹, D. Segev¹, J. Garonzik Wang¹, B. Trollinger¹, L. Lees¹, L. Toman¹, S. Shulder³, K. Dzintars¹, D. Ostrander¹
Risk Factors Associated with Severe COVID19 Illness in Kidney Transplant Recipients
E. Abuhelaiqa, M. Alkadi, H. Tohid, R. Elidrisi, R. Abdul Rahiman, M. F. Elshirbeny, T. A. Ghonaimi, A. I. Hamad, A. Nauman, A. A Aziz, O. Fituri, M. Asim, M. A. Othman, H. Al-Malki
Sars-cov-2 versus Non-sars-cov-2 Infection Among Solid Organ Transplant Recipients: Case Control Study
M. A. Mendoza¹, M. Raja¹, S. Anjan¹, S. C. Curel², G. Rosello³, A. Fernandez¹, A. Chandorkar⁴, C. O'Brien⁵, A. Phancao⁵, N. Sinha¹, R. Vianna¹, M. Loebe¹, C. Gaetano¹, J. Simkins¹, M. Morris¹, L. Abbo¹, J. Camargo¹, G. Guerra¹, Y. Natori¹
Seroprevalence of SARS-CoV-2 Antibodies in Transplant Recipients in a Croatian Transplant Center
A. Mrzljak¹, Z. Jurekovic¹, J. Pavicic Saric², L. Antolasic³, L. Milasincic³, I. Tabain³, T. Vilibic Cavlek³
Solid Organ Transplant Recipient Attitudes Towards a SARS-CoV-2 Vaccine
M. Ou¹, B. Boyarsky¹, L. Zeiser¹, T. Chiang¹, J. Ruddy¹, S. Rasmussen¹, J. Martin², J. Russell², C. Durand¹, R. Avery¹, W. Werbel¹, M. Cooper³, A. Massie¹, D. Segev¹, J. Garonzik-Wang¹
Systematic Screening of Kidney Transplant Patients Points Towards Deficits in Neutralizing Antibody Capacity Against Sars-cov-2
V. Wijtvliet¹, K. K. Ariën², J. Mariën², B. Peeters³, R. Hellemans⁴, A. Massart⁴, S. Van Hees¹, P. Moons⁵, H. Theeten⁶, P. Van Damme⁶, H. Goossens⁷, B. Y. De Winter¹, K. J. Ledeganck¹, D. Abramowicz⁴
T-Cell Responses in Solid Organ Transplant Recipients with SARS-CoV-2 Infection
V. H. Ferreira, T. M. Marinelli, T. Ku, M. Ierullo, B. Majchrzak-Kita, I. Bahinskaya, N. Pinzon, A. Humar, D. Kumar
The Gut Microbiota Diversity and Metabolite Production is Reduced in Liver Transplant Recipients and Associated with Post-Operative Infection
C. J. Lehmann, R. Keskey, R. Nayak, E. Littmann, E. Pamer, T. Baker